論文・総説 - 工藤　篤

201. Hiroko Matsunaga, Shinji Tanaka, Arihiro Aihara, Kousuke Ogawa, Satoshi Matsumura, Daisuke Ban, Takanori Ochiai, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Shigeki Arii and Minoru Tanabe. . A Novel Therapeutic Combination Sequentially Targeting Aurora B and Bcl-xL in Hepatocellular Carcinoma. Ann. Surg. Oncol. 2015.09; 22 (9): 3079-3086.

202. Daisuke Ban, Atsushi Kudo, Takumi Irie, Takanori Ochiai, Arihiro Aihara, Satoshi Matsumura, Shinji Tanaka, Minoru Tanabe. Advances in reduced port laparoscopic liver resection. Asian J Endosc Surg. 2015.02; 8 (1): 11-15. ( PubMed, DOI )

203. Okajima C, Arii S, Tanaka S, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanabe M.. Prognostic role of Child-Pugh score 5 and 6 in hepatocellular carcinoma patients who underwent curative hepatic resection. Am. J. Surg.. 2015.01; 209 (1): 199-205. ( PubMed, DOI )

204. Kudo A, Matusmura S, Ban D, Irie T, Ochiai T, Tanaka S, Arii S, Tanabe M.. Does the preoperative alpha-fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function? Hepatol. Res.. 2014.12; 44 (14): E437-E446. ( PubMed, DOI )

205. Kudo A, Tanaka S, Ban D, Matsumura S, Irie T, Ochiai T, Nakamura N, Arii S, Tanabe M.. Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis. J. Gastroenterol.. 2014.09; 49 (9): 1352-1361. ( PubMed, DOI )

206. Katsuta E, Tanaka S, Mogushi K, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Tanabe M, Arii S.. Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma. Am. J. Surg.. 2014.09; 208 (3): 450-456. ( PubMed, DOI )

207. Kudo A, Tanaka S, Matsumura S, Ban D, Irie T, Ochiai T, Nakamura N, Arii S.. Anatomic resection reduces the recurrence of solitary hepatocellular carcinoma <5 cm without macrovascular invasion. Am. J. Surg.. 2014.06; 207 (6): 863-869. ( PubMed, DOI )

208. Miura T, Ban D, Koyama T, Kudo A, Ochiai T, Irie T, Nakamura N, Tanaka S, Arii S.. Severe postoperative hemorrhage caused by antibody-mediated coagulation factor deficiencies: report of two cases. Surg. Today. 2014.05; 44 (5): 976-981. ( PubMed, DOI )

209. Kudo A, Igari T, Kumagai J, Tanaka S, Ban D, Noguchi N, Irie T, Nakamura N, Arii S.. A simple index to predict liver functional reserve after hepatectomy. Hepatogastroenterology. 2014.04; 61 712-716.

210. Ogawa K, Tanaka S, Matsumura S, Murakata A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanabe M, Arii S.. EpCAM-targeted therapy for human hepatocellular carcinoma. Ann. Surg. Oncol.. 2014.04; 21 (4): 1314-1322. ( PubMed, DOI )

211. Kudo A, Mogushi K, Takayama T, Matsumura S, Ban D, Irie T, Ochiai T, Nakamura N, Tanaka H, Anzai N, Sakamoto M, Tanaka S, Arii S.. Mitochondrial metabolism in the noncancerous liver determine the occurrence of hepatocellular carcinoma: a prospective study. J. Gastroenterol.. 2014.03; 49 (3): 502-510. ( PubMed, DOI )

212. Yasui Y, Kudo A, Kurosaki M, Matsuda S, Muraoka M, Tamaki N, Suzuki S, Hosokawa T, Ueda K, Matsunaga K, Nakanishi H, Tsuchiya K, Itakura J, Takahashi Y, Tanaka S, Asahina Y, Enomoto N, Arii S, Izumi N.. Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study. Oncology. 2014.01; 86 (1): 53-62. ( PubMed, DOI )

213. Ito H, Kudo A, Matsumura S, Ban D, Irie T, Ochiai T, Nakamura N, Tanaka S, Tanabe M. Mixed adenoneuroendocrine carcinoma of the colon progressed rapidly after hepatic rupture: report of a case. Int Surg. 2014; 99 (1): 40-44. ( PubMed, DOI )

214. Shunsuke Muramatsu, Shinji Tanaka, Kaoru Mogushi, Rama Adikrisna, Arihiro Aihara, Daisuke Ban, Takanori Ochiai, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Koh Nakayama, Hiroshi Tanaka, Shoji Yamaoka, Shigeki Arii. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course. Hepatology. 2013.07; 58 (1): 218-228. ( PubMed, DOI )

215. Atsushi Kudo, Ban D, Aihara A, Irie T, Ochiai T, Nakamura N, Tanaka S, Arii S. Decreased Mrp2 transport in severe macrovesicular fatty liver grafts. J Surg Res. 2012.12; 178 (2): 915-921. ( PubMed, DOI )

216. Tateno C, Miya F, Wake K, Kataoka M, Ishida Y, Yamasaki C, Yanagi A, Kakuni M, Wisse E, Verheyen F, Inoue K, Sato K, Kudo A, Arii S, Itamoto T, Asahara T, Tsunoda T, Yoshizato K. Morphological and microarray analyses of human hepatocytes from xenogeneic host livers. Lab Invest. 2012.11; ( PubMed, DOI )

217. Sato K, Tanaka S, Mitsunori Y, Mogushi K, Yasen M, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S. Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma; clinical and biological significance. Hepatology. 2012.11; ( PubMed, DOI )

218. Atsushi Kudo, Ban D, Akashi T, Kumagai J, Aihara A, Inokuchi M, Kojima K, Kawano T, Tanaka S, Arii S. Prognoses of GEP-NETS with undetermined malignant potentials of their primary sites. Hepatogastroenterology. 2012.09; 59 (118): 1682-1686. ( PubMed, DOI )

219. Atsushi Kudo, Akashi T, Kumagai J, Ban D, Inokuchi M, Kojima K, Kawano T, Tanaka S, Arii S. The Importance of Clinical Information in Patients with Gastroenteropancreatic Neuroendocrine Tumor. Hepato-gastroenterology. 2012.05; 59 (120): ( PubMed, DOI )

220. Adikrisna R, Tanaka S, Muramatsu S, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Yamaoka S, Arii S.. Identification of Pancreatic Cancer Stem Cells and Selective Toxicity of Chemotherapeutic Agents. Gastroenterology.. 2012.04;